| Bioactivity | EBV EBNA3A (379-387) is an antigenic epitope that may elicit the latent-specific CD8+ T cell response in HLA-B*07:02+ individuals[1]. |
| CAS | 160790-25-0 |
| Sequence | Arg-Pro-Pro-Ile-Phe-Ile-Arg-Arg-Leu |
| Shortening | RPPIFIRRL |
| Formula | C55H94N18O10 |
| Molar Mass | 1167.45 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Rowntree LC, et al. A Shared TCR Bias toward an Immunogenic EBV Epitope Dominates in HLA-B*07:02-Expressing Individuals. J Immunol. 2020 Sep 15;205(6):1524-1534. |
EBV EBNA3A (379-387)
CAS: 160790-25-0 F: C55H94N18O10 W: 1167.45
EBV EBNA3A (379-387) is an antigenic epitope that may elicit the latent-specific CD8+ T cell response in HLA-B*07:02+ in
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.